We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$97.1B
AUM Growth
+$3.73B
Cap. Flow
-$572M
Cap. Flow %
-0.59%
Top 10 Hldgs %
29.21%
Holding
7,380
New
424
Increased
3,249
Reduced
2,816
Closed
405

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$637M
2
WY icon
Weyerhaeuser
WY
+$340M
3
IQV icon
IQVIA
IQV
+$132M
4
HAL icon
Halliburton
HAL
+$123M
5
DOV icon
Dover
DOV
+$112M

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Healthcare 5.12%
3 Financials 4.53%
4 Consumer Discretionary 4.09%
5 Communication Services 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGR
7001
DELISTED
Avinger, Inc. Common Stock
AVGR
0
TTOO
7002
DELISTED
T2 Biosystems, Inc
TTOO
-5
Closed -$75K
FPL
7003
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
-972
Closed -$13K
YTEN
7004
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
EIGR
7005
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
-237
Closed -$64.6K
AAU
7006
DELISTED
Almaden Minerals Ltd
AAU
$0 ﹤0.01%
56
BPTH
7007
DELISTED
Bio-Path Holdings Inc
BPTH
-10
Closed -$16K
ONCT
7008
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
0
NETI
7009
PUT
DELISTED
Eneti Inc.
NETI
-6,929
Closed -$458K
CTG
7010
DELISTED
Computer Task Group, Inc.
CTG
$0 ﹤0.01%
36
-100
-74% -$537
UFAB
7011
DELISTED
Unique Fabricating, Inc.
UFAB
-9,695
Closed -$92K
CGRN
7012
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$0 ﹤0.01%
7
+5
+250% +$32
SPPI
7013
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-1,100
Closed -$8K
NOVN
7014
DELISTED
Novan, Inc. Common Stock
NOVN
-454
Closed -$18K
LSI
7015
PUT
DELISTED
Life Storage, Inc.
LSI
-8,100
Closed -$400K
AZRE
7016
DELISTED
Azure Power Global Limited
AZRE
$0 ﹤0.01%
+7
New +$109
ROCC
7017
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
-5,207
Closed -$192K
TA
7018
DELISTED
TravelCenters of America LLC
TA
-289
Closed -$6K
OIG
7019
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$0 ﹤0.01%
2
-16
-89% -$2.29K
MYOV
7020
DELISTED
Myovant Sciences Ltd.
MYOV
-10,877
Closed -$127K
QUMU
7021
DELISTED
Qumu Corp.
QUMU
$0 ﹤0.01%
59
SWIR
7022
CALL
DELISTED
Sierra Wireless
SWIR
-200
Closed -$6K
SPNE
7023
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-24
Closed
STON
7024
DELISTED
StoneMor Inc.
STON
-18
Closed
SRLP
7025
DELISTED
SPRAGUE RESOURCES LP
SRLP
-384
Closed -$11K

Similar funds

Barclays's Q3 2017 Portfolio in Review

As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.

  • Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
  • Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
  • Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
  • Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
  • Barclays opened 424 new positions and closed 405 in Q3 2017.
  • Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.

Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.